Clinical Trials in Cleveland

Showing 2201-2220 of 19,775 trials

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

NCT01068782

This study was conducted in subjects with grade IV astrocytic tumors (a type of cancer that can occur in the brain or spinal cord) in first or second relapse.

Astrocytic Tumors

Exelixis19 participantsStarted Apr 2010

Birmingham, Alabama, United States • Encinitas, California, United States • Pleasant Hill, California, United States +16 more locations

Active Not RecruitingPhase 2< 1 mile

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

NCT05601752

This is a phase 2, open-label, randomized, non-comparative clinical trial to evaluate the clinical outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab in human leukocyte antigen (HLA) A2+ subjects with recurrent ovarian cancer positive for MAGE-A4.

Ovarian Cancer

USWM CT, LLC66 participantsStarted Jun 2023

Scottsdale, Arizona, United States • Duarte, California, United States • Augusta, Georgia, United States +20 more locations

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

Find Trials by Condition in Cleveland

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

The ENCIRCLE Trial

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot

Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

Clenbuterol to Target DUX4 in FSHD

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Sonication-based OCD Neurosurgical Intervention Via Capsulotomy